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Background
Chronic Cluster Headache (CCH) is an infrequent form of
Cluster Headache, defined by the absence of remission
periods. Medical treatments are few, sometimes ineffective
and poorly tolerated. Rotigotine was recently reported as
useful in a single patient with CCH.
Aim
Reporting the results observed using rotigotine in four
cases with CCH.
Cases report
All patients received a diagnosis of CCH according to
ICHD-3 Beta. Brain imaging and neurological examination
were normal. Patients were 61, 67, 49 and 45 respectively.
Verapamil, carbolithium and steroids were used
unsuccessfully.
Case 1: he had tried Gammacore and pregabalin, too,
ineffectively. Transdermal rotigotine was started at the
dose of 2 mg/die. After a few days, only scarce, minor
attacks persisted, and were stopped by titrating posology
to 4 mg/die.
Case 2: rotigotine was titrated up to 6 mg/die, without
any beneficial effect, and after a month it was
discontinuated.
Case 3 and 4: titration proceded to 4 mg/die, for persis-
tence of minor attacks with lower doses. Lasting remission
has been observed since.
No adverse event has been reported by the patients.
Conclusions
Rotigotine is a non-ergoline D3-like receptor agonist. Its
availability in the transdermal form and its safety profile
make it well accepted by patients. The four subjects whose
cases we reported did not show any adverse event. Three
of them showed initial but definite benefit from this
therapy and are currently free from pain and under
follow-up. We think that rotigotine should be considered
in the management of CCH unresponsive to common
treatment.
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